The UAE’s largest medicinal drugs manufacturer Gulf Pharmaceutical Industries (Julphar) has recorded a sales revenue worth Dhs630.3 million for the first half the current year, showing 13.5 per cent year-on-year (yoy) growth in sales of medicines. The
During first half of 2012 Gulf Pharmaceutical industries (Julphar) registered a sale of AED 630.3 million, reflecting a growth of 13.5 percent compared with AED 555 million of first half of 2011. Julphar reported a net profit of AED 110.80 million,
SPIMACO ADDWAEIH announces the interim financial results for the period ended June 30, 2012: 1. The net income for the second quarter amounted to SR 90.1 million compared to SR 60.8 million for the same quarter of prior year, representing an increase of